Overall, cannabinoids provide modest, condition-specific analgesia and should be considered adjunctive rather than first-line options, reserved for patients unresponsive to conventional therapy.
Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin – CED Clinic
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Chronic PainNeuropathic PainEvidence-Based MedicinePain ManagementClinical Practice Why This MattersChronic pain affects over 50 million...